Avian Influenza
HepaLife's PBS-1 cells for avian influenza vaccine achieve research objective
Published in Vaccine Weekly, January 3rd, 2007
Pathogen-free cells are critical for the rapid development of cell-culture-based vaccine production to help protect against the spread of influenza viruses among humans, including potentially the high-pathogenicity H5N1 avian flu virus.
"I'm very pleased that independent lab tests have confirmed our PBS-1 cells are pathogen-free. This is especially good news for HepaLife's researchers, who can now confidently accelerate our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-01-03)
More Articles from Vaccine Weekly
- Hepatitis C Virus
Inovio Biomedical partner Tripep applies for phase I study of hepatitis C DNA vaccine - DNA Vaccines
Scientists at Beth Israel Deaconess Medical Center, Division of Viral Pathogenesis release new data on DNA vaccines - Vaccine Efficacy
Researchers from Mahidol University detail findings in vaccine efficacy - Atherosclerosis Vaccine
Human clinical trials will begin at the end of next year on first vaccine against atherosclerosis - Business Update
Crucell awarded contracts of over $230 million for Quinvaxem and Hepavax-Gene vaccines - Business Update
Immunomedics reports on 2006 annual meeting of shareholders - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
